Under pathological conditions, such as wound healing or tumor formation it has recently been shown that Ets-1 competitively inhibits the function of another Ets factor Fli-1 to promote the expression of CCN2, thereby promoting extracellular matrix deposition during cancer [45]. This evidence concerns the gene CCN2 and neoplasm.